Connection

Fabrice Carrat to Adult

Back to Details
This is a "connection" page, showing publications Fabrice Carrat has written about Adult.
Fabrice Carrat
Connection Strength
0.120
Adult
  1. Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study. Int J Epidemiol. 2021 Nov 10; 50(5):1458-1472.
    View in: PubMed
    Score: 0.016
  2. Incidence and risk factors of COVID-19-like symptoms in the French general population during the lockdown period: a multi-cohort study. BMC Infect Dis. 2021 Feb 10; 21(1):169.
    View in: PubMed
    Score: 0.015
  3. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort. Eur J Epidemiol. 2021 Feb; 36(2):219-222.
    View in: PubMed
    Score: 0.015
  4. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet. 2019 Apr 06; 393(10179):1453-1464.
    View in: PubMed
    Score: 0.013
  5. Are Posterior Oropharyngeal Saliva Specimens an Acceptable Alternative to Nasopharyngeal Sampling for the Monitoring of SARS-CoV-2 in Primary-Care Settings? Viruses. 2021 04 26; 13(5).
    View in: PubMed
    Score: 0.004
  6. When lockdown policies amplify social inequalities in COVID-19 infections: evidence from a cross-sectional population-based survey in France. BMC Public Health. 2021 04 12; 21(1):705.
    View in: PubMed
    Score: 0.004
  7. Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study. Lancet Public Health. 2021 06; 6(6):e408-e415.
    View in: PubMed
    Score: 0.004
  8. Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population. Infect Dis Now. 2021 Jun; 51(4):380-382.
    View in: PubMed
    Score: 0.004
  9. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study. Gut. 2020 05; 69(5):852-858.
    View in: PubMed
    Score: 0.003
  10. Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort. BMC Infect Dis. 2019 Apr 02; 19(1):300.
    View in: PubMed
    Score: 0.003
  11. Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review. Leuk Lymphoma. 2019 07; 60(7):1782-1788.
    View in: PubMed
    Score: 0.003
  12. Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. Gastroenterology. 2018 08; 155(2):337-346.e10.
    View in: PubMed
    Score: 0.003
  13. Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort. Am J Hematol. 2018 May; 93(5):E114-E117.
    View in: PubMed
    Score: 0.003
  14. High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn's Disease. Clin Gastroenterol Hepatol. 2018 06; 16(6):892-899.e2.
    View in: PubMed
    Score: 0.003
  15. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease. JAMA. 2017 Nov 07; 318(17):1679-1686.
    View in: PubMed
    Score: 0.003
  16. Testing for hepatitis B virus alone does not increase vaccine coverage in non-immunized persons. World J Gastroenterol. 2017 Oct 14; 23(38):7037-7046.
    View in: PubMed
    Score: 0.003
  17. Comparing Inpatient Satisfaction Collected via a Web-Based Questionnaire Self-Completion and Through a Telephone Interview: An Ancillary Study of the SENTIPAT Randomized Controlled Trial. J Med Internet Res. 2017 08 23; 19(8):e293.
    View in: PubMed
    Score: 0.003
  18. Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study. Gut. 2018 07; 67(7):1261-1268.
    View in: PubMed
    Score: 0.003
  19. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial. Lancet Gastroenterol Hepatol. 2017 03; 2(3):177-188.
    View in: PubMed
    Score: 0.003
  20. Evaluation of Four Commercial Multiplex Molecular Tests for the Diagnosis of Acute Respiratory Infections. PLoS One. 2015; 10(6):e0130378.
    View in: PubMed
    Score: 0.003
  21. Intense co-circulation of non-influenza respiratory viruses during the first wave of pandemic influenza pH1N1/2009: a cohort study in Reunion Island. PLoS One. 2012; 7(9):e44755.
    View in: PubMed
    Score: 0.002
  22. Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One. 2011 May 10; 6(5):e19621.
    View in: PubMed
    Score: 0.002
  23. Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02. Antivir Ther. 2009; 14(2):211-9.
    View in: PubMed
    Score: 0.002
  24. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology. 2005 Feb; 128(2):297-303.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.